Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023511 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers
A NA study of ICU Acquired Weakness, sponsored by Health Discovery Labs.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06023511 is a NA study of ICU Acquired Weakness that has completed, run by Health Discovery Labs. The registered enrollment target is 8 participants, below the 2,113-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06023511, a NA study of ICU Acquired Weakness, has completed, sponsored by Health Discovery Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Every patient admitted to the Intensive Care Unit (ICU) is at risk of developing "Intensive Care Unit Acquired Weakness" (ICUAW). ICUAW is associated with increased rate of mortality, prolonged duration of mechanical ventilation, ICU and hospital stay, rehabilitation time, and reduced quality of life. Currently, there is no effective treatment for ICUAW. Health Discovery Labs is conducting a research study to evaluate the safety of using an innovative experimental medical device in ICU settings that could mitigate ICUAW. This study is meant to demonstrate whether this new device interferes with standard ICU monitors.
Conditions Studied
Interventions
- DEVICE Electrical muscle stimulation
Study Locations (1)
Texas
- Ascension Texas Clinical Education Center (CEC) - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-08-22 |
| Est. Completion | 2023-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06023511
The ClinicalTrials.gov registry entry for NCT06023511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,113-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (100% lower). The listed sponsor is Health Discovery Labs, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ICU Acquired Weakness appearing as the primary indexed condition, and to 1 intervention - of which Electrical muscle stimulation is the first listed.
NCT06023511 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06023511 about?
NCT06023511 is a clinical study titled "Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers". Every patient admitted to the Intensive Care Unit (ICU) is at risk of developing "Intensive Care Unit Acquired Weakness" (ICUAW). ICUAW is associated with increased rate of mortality, prolonged duration of mechanical ventilation, ICU and hospital stay, rehabilitation time, and reduced quality of lif...
What is the current status of trial NCT06023511?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-08-22. Estimated completion is 2023-08-23.
What conditions does trial NCT06023511 study?
This clinical trial studies the following conditions: ICU Acquired Weakness.
What interventions are being tested in trial NCT06023511?
The interventions under investigation include: Electrical muscle stimulation (DEVICE).
Who is sponsoring clinical trial NCT06023511?
This trial is sponsored by Health Discovery Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023511 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ICU Acquired Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Economic & Staffing Strategies in the ICU
RECRUITING · NA
-
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
RECRUITING · NA
-
Diagnosing Intensive Care Unit (ICU) Acquired Weakness
COMPLETED · NA
-
Muscle Recovery After Critical Illness
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.